AN ANALYSIS OF THE CONTACT PHASE OF BLOOD-COAGULATION - EFFECTS OF SHEAR RATE AND SURFACE ARE INTERTWINED

被引:20
作者
GREGORY, K [1 ]
BASMADJIAN, D [1 ]
机构
[1] UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA
关键词
MATHEMATICAL MODEL; FACTOR-XII; KALLIKREIN; HMWK; CASCADE; MASS TRANSFER;
D O I
10.1007/BF02390376
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This work analyzes, for the first time, the combined role of blood flow, protein transport and the reaction network of the contact phase up to the ''common pathway'' of the blood coagulation cascade. The model is comprised of a set of 20 dominant reactions with 11 components. Systems of ODEs reducible to 4 coupled equations describe rigorously the dynamic behavior, while systems of algebraic equations, reducible to a single polynomial equation, model the steady state concentrations of the coagulants. The analysis showed that there is never more than one stable steady state. This is in contrast to the analysis of common pathway that gives rise to multiple concentration states. It also revealed a general robustness of the system to changes in procoagulant concentrations, inhibition rates and most activation rate constants. The system is largely impervious to the level of activated Factor XII, given that a trace (non-zero) level is present. In contrast, the system displays a dual response to flow and surface activity: A change in either of these factors alone can promote, have no effect on, or (in the case of flow) impede the progress of coagulation, depending on the value of the other factor. Their effects must therefore be examined in unison. These results may help resolve contradictory findings attributed to one or the other factor alone.
引用
收藏
页码:184 / 193
页数:10
相关论文
共 22 条
[11]   SURFACE-DEPENDENT ACTIVATION OF HUMAN FACTOR-XII (HAGEMAN-FACTOR) BY KALLIKREIN AND ITS LIGHT CHAIN [J].
ROSING, J ;
TANS, G ;
GRIFFIN, JH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 151 (03) :531-538
[12]   CONTRIBUTION OF PLASMA PROTEASE INHIBITORS TO THE INACTIVATION OF KALLIKREIN IN PLASMA [J].
SCHAPIRA, M ;
SCOTT, CF ;
COLMAN, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (02) :462-468
[13]   INACTIVATION OF FACTOR XIA BY PLASMA PROTEASE INHIBITORS - PREDOMINANT ROLE OF ALPHA-1-PROTEASE INHIBITOR AND PROTECTIVE EFFECT OF HIGH MOLECULAR-WEIGHT KININOGEN [J].
SCOTT, CF ;
SCHAPIRA, M ;
JAMES, HL ;
COHEN, AB ;
COLMAN, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (04) :844-852
[14]   CLEAVAGE OF HUMAN HIGH MOLECULAR-WEIGHT KININOGEN MARKEDLY ENHANCES ITS COAGULANT ACTIVITY - EVIDENCE THAT THIS MOLECULE EXISTS AS A PROCOFACTOR [J].
SCOTT, CF ;
SILVER, LD ;
SCHAPIRA, M ;
COLMAN, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (04) :954-962
[15]  
SILVERBERG M, 1982, BLOOD, V60, P64
[16]   INHIBITION OF FACTOR-XIA BY ANTITHROMBIN-III [J].
SOONS, H ;
JANSSENCLAESSEN, T ;
TANS, G ;
HEMKER, HC .
BIOCHEMISTRY, 1987, 26 (15) :4624-4629
[17]  
TAIT JF, 1987, J BIOL CHEM, V262, P11651
[18]  
TANS G, 1983, J BIOL CHEM, V258, P8215
[19]  
TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139
[20]   INTERACTION OF HUMAN-PLASMA KALLIKREIN AND ITS LIGHT CHAIN WITH C1BAR INHIBITOR [J].
VANDERGRAAF, F ;
KOEDAM, JA ;
GRIFFIN, JH ;
BOUMA, BN .
BIOCHEMISTRY, 1983, 22 (20) :4860-4866